glp-1 companies supplements are everywhere—but do they actually work? As demand for weight-loss drugs grows, are cashing in on products that claim to support GLP-1 goals, often with little oversight. Tap the 20 Companies in Glucagon-Like Peptide-1

In this episode of the CardioNerds Cardiovascular Prevention Series, we discuss the clinical implementation of glucagon-like peptide-1 (GLP-1) receptor agonists

Attia SM, Alshamrani AA, Ahmad SF, Albekairi NA, Nadeem A, Attia MS, et al

Some of the brand names include Ozempic, Wegovy, Mounjaro and ZepBound

Sarah explains that after proving bitter taste receptors exist in the gut and that they express appetite-suppressing hormones, the team built a high-throughput robotic screening system to test over 1,000 different plant extracts

This has constrained the revenue potential of upstream and downstream players in the value chain

Ozempic, for example, is approved by the FDA to reduce the risk of cardiovascular problems in people with type 2 diabetes and heart disease, while Zepbound is approved to treat obstructive sleep apnea